Contrast Media Contrast Agent Market Top Growth Factors and Future Trends 2024
Growth in the contrast agent market can primarily be attributed to
factors such as the increasing prevalence of cancer & CVD,
regulatory approval of a growing number of contrast agents, and the
rising volume of CT & MRI examinations. However, the side effects
and allergic reactions associated with contrast agents are expected to
limit market growth to a certain extent.
According to research report the global contrast media market
is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0
billion in 2019, growing at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
North America to dominate the market in 2019
North
America, Europe, Asia Pacific, and the Rest of the World (RoW) are the
regions considered for geographic analysis of the global contrast agent
market study. North America is expected to account for the largest share
of the global contrast media industry. The large share of North America
is attributed to the increasing number of diagnostic imaging units and
examinations, growing aging population & rising prevalence of
chronic conditions in the US, significant focus & government
investments in the field of medical imaging, and increasing research
activities in Canada.
By type, the iodinated contrast media segment is expected to account for the largest share of the contrast media market in 2019
Based
on type, the contrast media market is segmented into iodinated contrast
media, gadolinium-based contrast media, barium-based contrast media,
and microbubble contrast media. In 2019, the iodinated contrast media
segment is estimated to account for the largest share of the contrast
media industry. The large share of this segment can be attributed due to
its high usage in CT examinations coupled with the fact that it can be
used in almost all body parts.
By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2019
Based
on modality, the contrast agent market is segmented into X-ray/CT, MRI,
and ultrasound procedures. In 2019, X-ray/CT procedures segment is
expected to command the largest share of the global contrast media
market. The large share of this segment can be attributed to the
increasing number of CT examinations across the globe, coupled with
advancements in CT imaging technologies.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
The
prominent players in the global contrast media market include GE
Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet
(France) are the major players operating in the market. Other prominent
players in the market are Lantheus (US), Daiichi Sankyo (Japan),
Unijules (India), J.B. Chemicals (India), Sanochemia (Austria), Taejoon
Pharm (South Korea), Jodas (India), and Magnus Health (India).
Comments
Post a Comment